Deep Track Capital LP 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:41 am Sale | 2024-09-30 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital LP | 674,833 2.240% | -1,369,674 (-66.99%) | Filing |
| 2024-02-14 08:53 am Sale | 2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital LP | 2,044,507 6.790% | -793,311 (-27.95%) | Filing |
| 2023-02-14 08:56 am Purchase | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital LP | 2,837,818 9.430% | 356,818 (+14.38%) | Filing |
| 2022-10-21 4:01 pm Purchase | 2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital LP | 2,481,000 8.250% | 2,481,000 (New Position) | Filing |